Business Development and Strategic Planning
United States of America
Clayton Fletcher joined Idera as Senior Vice President of Business Development and Strategic Planning in January 2015. Prior to joining Idera, Mr. Fletcher served as Vice President, Business Development & Project Management at ViroPharma from June 2005 to January 2014 and as a management team member from January 2011 to January 2014. In 2003, he assumed the position of Director Business Development and Project Management. Mr. Fletcher joined ViroPharma in April 2001 as Project Leader. From 1997 until 2001, he was Senior Project Manager at SmithKlineBeecham Pharmaceuticals. From 1996 until 1997, Mr. Fletcher was Project Scientist at Becton-Dickson and Company. From 1993 until 1996, he held positions with increasing responsibilities at Intracel Corporation. From 1991 to 1993, he was Senior Associate Scientist at Centocor Inc. Mr. Fletcher received Bachelor of Science and Master of Science degrees in biology from Wake Forest University.
company developing novel nucleic acid therapeutic approaches for the treatment of certain cancers and rare diseases. Idera’s immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while our third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA.